It is a specific antagonist of the NK1R, a receptor for SP and neurokinins A and B. So, aprepitant has been successfully tested in chronic pruritus associated with dermatological, hematological, or systemic diseases as well as drug-induced pruritus. The gene discussed is TAC1; the disease is Pruritus.